For better or worse: FFAR1 and FFAR4 signaling in cancer and diabetes

Molecular Pharmacology

Volumn 90, Issue 6, 2016, Pages 738-743

  Houthuijzen, J M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FREE FATTY ACID RECEPTOR 4; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 40; INSULIN; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

CALORIC INTAKE; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; DIABETES MELLITUS; FAT INTAKE; HUMAN; INFLAMMATION; INSULIN RELEASE; MELANOMA; NEOPLASM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; DRUG DELIVERY SYSTEM; METABOLISM;

DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84996549550     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.116.105932     Document Type: Review

References (52)

1. Anbazhagan AN, Priyamvada S, Gujral T., Bhattacharyya S, Alrefai WA, Dudeja P.K., and Borthakur A (2016) A novel anti-inflammatory role of GPR120 in intestinal epithelial cells. Am J Physiol Cell Physiol 310:C612-C621.
2. Araki T, Hirayama M, Hiroi S., and Kaku K (2012) GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes Obes Metab 14:271-278.
3. Briscoe CP, Peat AJ, McKeown S.C., Corbett DF, Goetz AS, Littleton TR, McCoy D.C., Kenakin TP, Andrews JL, Ammala C, et al (2006) Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 148:619-628.
4. Briscoe CP, Tadayyon M, Andrews J.L., Benson WG, Chambers JK, Eilert MM, Ellis C, Elshourbagy NA, Goetz AS, Minnick DT, et al. (2003) The orphan G proteincoupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278:11303-11311.
5. Cartoni C, Yasumatsu K, Ohkuri T., Shigemura N, Yoshida R, Godinot N., le Coutre J, Ninomiya Y, and Damak S (2010) Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci 30:8376-8382.
6. Christiansen E, Hansen SV, Urban C, Hudson B.D., Wargent ET, Grundmann M, Jenkins L, Zaibi M., Stocker CJ, Ullrich S, et al. (2013) Discovery of TUG-770: a highly potent free fatty acid receptor 1 (ffa1/gpr40) agonist for treatment of type 2 diabetes. ACS Med Chem Lett 4:441-445.
7. Christensen LW, Kuhre RE, Janus C, Svendsen B., and Holst JJ (2015) Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine. Physiol Rep 3:e12551.
8. Feng XT, Leng J, Xie Z., Li SL, Zhao W, and Tang QL (2012) GPR40: a therapeutic target for mediating insulin secretion (review). Int J Mol Med 30:1261-1266.
9. Fukushima K, Takahashi K, Fukushima N., Honoki K, and Tsujiuchi T (2016) Different effects of GPR120 and GPR40 on cellular functions stimulated by 12-O-tetradecanoylphorbol-13-acetate in melanoma cells. Biochem Biophys Res Commun 475:25-30.
10. Fukushima K, Yamasaki E, Ishii S., Tomimatsu A, Takahashi K, Hirane M., Fukushima N, Honoki K, and Tsujiuchi T (2015) Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells. Biochem Biophys Res Commun 465:512-515.
11. Hansen SV, Christiansen E, Urban C., Hudson BD, Stocker CJ, Due-Hansen ME, Wargent ET, Shimpukade B, Almeida R., Ejsing CS, et al. (2016) Discovery of a potent free fatty acid 1 receptor agonist with low lipophilicity, low polar surface area, and robust in vivo efficacy. J Med Chem 59:2841-2846.
12. Hauge M, Vestmar MA, Husted A.S., Ekberg JP, Wright MJ, Di Salvo J, Weinglass AB, Engelstoft M.S., Madsen AN, Lückmann M, et al. (2014) GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo. Mol Metab 4:3-14.
13. Hirasawa A, Tsumaya K, Awaji T., Katsuma S, Adachi T, Yamada M., Sugimoto Y, Miyazaki S, and Tsujimoto G (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-94.
14. Hopkins MM, Zhang Z, Liu Z., and Meier KE (2016) Eicosopentaneoic acid and other free fatty acid receptor agonists inhibit lysophosphatidic acid- and epidermal growth factor-induced proliferation of human breast cancer cells. J Clin Med 5:E16.
15. Houthuijzen JM, Oosterom I, Hudson B.D., Hirasawa A., Daenen LGM, Kersbergen A, McLean C.M., Hansen SVF, van Jaarsveld MTM, Peeper DS, et al. (2016) GPR120/FFAR4 activation by fatty acid 16:4(n-3) plays a key role in resistance to chemotherapy. Cell Reports (under revision).
16. Hudson BD, Shimpukade B, Mackenzie A.E., Butcher AJ, Pediani JD, Christiansen E, Heathcote H., Tobin AB, Ulven T, and Milligan G (2013) The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol 84:710-725.
17. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A., Hara T, Yengo L, Kimura I., Leloire A, Liu N, Iida K., et al. (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483:350-354.
18. Ishii S, Hirane M, Kato S., Fukushima N, and Tsujiuchi T (2015a) Opposite effects of GPR120 and GPR40 on cell motile activity induced by ethionine in liver epithelial cells. Biochem Biophys Res Commun 456:135-138.
19. Ishii S, Kitamura Y, Hirane M., Tomimatsu A, Fukushima K, Takahashi K., Fukushima N, Honoki K, and Tsujiuchi T (2015b) Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells. Mol Carcinog DOI: 10.1002/mc.22408 (published aheadofprint).
20. Itoh Y, Kawamata Y, Harada M., Kobayashi M, Fujii R, Fukusumi S., Ogi K, Hosoya M, Tanaka Y., Uejima H, et al. (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173-176.
21. Iwasaki K, Harada N, Sasaki K., Yamane S, Iida K, Suzuki K., Hamasaki A, Nasteska D, Shibue K., Joo E, et al. (2015) Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion. Endocrinology 156:837-846.
22. Kaku K, Enya K, Nakaya R., Ohira T, and Matsuno R (2015) Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial. Diabetes Obes Metab 17:675-681.
23. Kebede M, Alquier T, Latour M.G., Semache M., Tremblay C, and Poitout V (2008) The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding. Diabetes 57:2432-2437.
24. Kita T, Kadochi Y, Takahashi K., Fukushima K, Yamasaki E, Uemoto T., Hirane M, Fukushima N, Honoki K., and Tsujiuchi T (2016) Diverse effects of G-proteincoupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells. Exp Cell Res 342:193-199.
25. Konda VR, Desai A, Darland G., Grayson N, and Bland JS (2014) KDT501, a derivative from hops, normalizes glucose metabolism and body weight in rodent models of diabetes. PLoS One 9:e87848.
26. Lamri A, Bonnefond A, Meyre D., Balkau B, Roussel R, Marre M., Froguel P, and Fumeron F; D.E.S.I.R. Study Group (2016) Interaction between GPR120 p. R270H loss-of-function variant and dietary fat intake on incident type 2 diabetes risk in the D.E.S.I.R. study. Nutr Metab Cardiovasc Dis DOI: 10.1016/j.numecd.2016.04.010 (published ahead of print).
27. Lan H, Hoos LM, Liu L, Tetzloff G., Hu W, Abbondanzo SJ, Vassileva G, Gustafson E.L., Hedrick JA, and Davis HR (2008) Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease. Diabetes 57:2999-3006.
28. Leifke E, Naik H, Wu J., Viswanathan P, Demanno D, Kipnes M., and Vakilynejad M (2012) A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes. Clin Pharmacol Ther 92:29-39.
29. Li M, Meng X, Xu J., Huang X, Li H, Li G., Wang S, Man Y, Tang W., and Li J (2016a) GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway. Sci Rep 6:25237.
30. Li X, Yu Y, and Funk CD (2013) Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). FASEB J 27:4987-4997.
31. Li Z, Qiu Q, Geng X., Yang J, Huang W, and Qian H (2016b) Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development. Expert Opin Investig Drugs 25:871-890.
32. 2 and plays an anti-inflammatory role in macrophages. Immunology 143:81-95.
33. Liu Z, Hopkins MM, Zhang Z, Quisenberry C.B., Fix LC, Galvan BM, and Meier KE (2015) Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J Pharmacol Exp Ther 352:380-394.
34. Mancini AD, Bertrand G, Vivot K., Carpentier É, Tremblay C, Ghislain J, Bouvier M, and Poitout V (2015) b-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1. J Biol Chem 290:21131-21140.
35. Milligan G, Alvarez-Curto E, Watterson K.R., Ulven T., and Hudson BD (2015) Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. Br J Pharmacol 172:3254-3265.
36. Miyamoto J, Hasegawa S, Kasubuchi M., Ichimura A, Nakajima A, and Kimura I (2016) Nutritional signaling via free fatty acid receptors. Int J Mol Sci 17:450.
37. Mobraten K, Haug TM, Kleiveland C.R., and Lea T (2013) Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells. Lipids Health Dis 12:101.
38. Munkarah A, Mert I, Chhina J., Hamid S, Poisson L, Hensley-Alford S, Giri S., and Rattan R (2016) Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence. Gynecol Oncol 141:72-79.
39. Oh DY, Talukdar S, Bae E.J., Imamura T., Morinaga H, Fan W, Li P., Lu WJ, Watkins SM, and Olefsky JM (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687-698.
40. Oh DY, Walenta E, Akiyama T.E., Lagakos WS, Lackey D, Pessentheiner AR, Sasik R, Hah N., Chi TJ, Cox JM, et al. (2014) A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med 20:942-947.
41. 2+ signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice. Gastroenterology 146:995-1005.
42. Reimann F and Gribble FM (2016) Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion. J Diabetes Investig 7 (Suppl 1):13-19.
43. Salehi A, Flodgren E, Nilsson N.E., Jimenez-Feltstrom J, Miyazaki J, Owman C., and Olde B (2005) Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res 322:207-215.
44. Srivastava A, Yano J, Hirozane Y., Kefala G, Gruswitz F, Snell G., Lane W, Ivetac A, Aertgeerts K., Nguyen J, et al. (2014) High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature 513:124-127.
45. Stone VM, Dhayal S, Brocklehurst K.J., Lenaghan C., Sörhede Winzell M, Hammar M, Xu X, Smith DM, and Morgan NG (2014) GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia 57:1182-1191.
46. Sum CS, Tikhonova IG, Neumann S, Engel S., Raaka BM, Costanzi S, and Gershengorn MC (2007) Identification of residues important for agonist recognition and activation in GPR40. J Biol Chem 282:29248-29255.
47. Tan CP, Feng Y, Zhou Y.P., Eiermann GJ, Petrov A, Zhou C, Lin S., Salituro G, Meinke P, Mosley R., et al. (2008) Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Diabetes 57:2211-2219.
48. Tomita T, Masuzaki H, Iwakura H., Fujikura J, Noguchi M, Tanaka T., Ebihara K, Kawamura J, Komoto I., Kawaguchi Y, et al. (2006) Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion. Diabetologia 49:962-968.
49. Tsujihata Y, Ito R, Suzuki M., Harada A, Negoro N, Yasuma T., Momose Y, and Takeuchi K (2011) TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. J Pharmacol Exp Ther 339:228-237.
50. Ulven T and Christiansen E (2015) Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4/GPR120. Annu Rev Nutr 35: 239-263.
51. Williams-Bey Y., Boularan C, Vural A., Huang NN, Hwang IY, Shan-Shi C, and Kehrl JH (2014) Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-kB activation and enhancing autophagy. PLoS One 9:e97957.
52. Wu Q, Wang H, Zhao X., Shi Y, Jin M, Wan B., Xu H, Cheng Y, Ge H., and Zhang Y (2013) Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 32:5541-5550.